Tau Pathology and Parietal White Matter Lesions Have Independent but Synergistic Effects on Early Development of Alzheimer's Disease

Por Hertze, Joakim, Palmqvist, Sebastian, Minthon, Lennart, Hansson, Oskar
Publicado em 2013

Changes in cerebrospinal fluid and blood plasma levels of IGF-II and its binding proteins in Alzheimer’s disease: an observational study

Por Hertze, Joakim, Nägga, Katarina, Minthon, Lennart, Hansson, Oskar
Publicado em 2014

Cerebrospinal fluid neurogranin and YKL‐40 as biomarkers of Alzheimer's disease

Por Janelidze, Shorena, Hertze, Joakim, Zetterberg, Henrik, Landqvist Waldö, Maria, Santillo, Alexander, Blennow, Kaj, Hansson, Oskar
Publicado no Ann Clin Transl Neurol (2015)

Comparison of Brief Cognitive Tests and CSF Biomarkers in Predicting Alzheimer’s Disease in Mild Cognitive Impairment: Six-Year Follow-Up Study

Por Palmqvist, Sebastian, Hertze, Joakim, Minthon, Lennart, Wattmo, Carina, Zetterberg, Henrik, Blennow, Kaj, Londos, Elisabet, Hansson, Oskar
Publicado em 2012

Evaluating Amyloid-β Oligomers in Cerebrospinal Fluid as a Biomarker for Alzheimer’s Disease

Por Hölttä, Mikko, Hansson, Oskar, Andreasson, Ulf, Hertze, Joakim, Minthon, Lennart, Nägga, Katarina, Andreasen, Niels, Zetterberg, Henrik, Blennow, Kaj
Publicado em 2013

Increased blood-brain barrier permeability is associated with dementia and diabetes but not amyloid pathology or APOE genotype

Por Janelidze, Shorena, Hertze, Joakim, Nägga, Katarina, Nilsson, Karin, Nilsson, Christer, Wennström, Malin, van Westen, Danielle, Blennow, Kaj, Zetterberg, Henrik, Hansson, Oskar
Publicado no Neurobiol Aging (2017)